12th Annual Clinical Trials in Oncology Europe 2025

26 - 27

November

2025
  • Marriott Munich City West , Munich, Germany
  • Free
  • Why attend?
  • Agenda
  • Advisory Board
  • Speakers
  • Plan Your Visit
  • Event Gallery
  • 2025 Sponsors
  • Media Centre
  • Why partner?
  • Contact Us
close

2025 Sponsors Included:

Back

Company Information

Medidata is powering smarter treatments and healthier people through digital solutions to support clinical trials. Celebrating 25 years of ground-breaking technological innovation across more than 35,000 trials and 10 million patients, Medidata offers industry-leading expertise, analytics-powered insights, and the largest patient-level historical clinical trial data set in the world. More than 1 million registered users across approximately 2,300 customers trust Medidata’s seamless, end-to-end platform to improve patient experiences, accelerate clinical breakthroughs, and bring therapies to market faster. A Dassault Systèmes brand (Euronext Paris: FR0014003TT8, DSY.PA), Medidata is headquartered in New York City and has been recognized as a Leader by Everest Group and IDC. Discover more at www.medidata.com and follow us @Medidata.

Company Website

To learn more, please visit our website - https://www.medidata.com

Next Sponsor
Back

Company Information

ARENSIA Exploratory Medicine, a German-based company, is a leader in “first-in-patient” Phase IB and II/Proof-of-Concept clinical trials across a wide range of disease areas. With 14 proprietary research clinics and cutting-edge Phase I infrastructure, ARENSIA accelerates the early detection of efficacy signals for new therapies at an unparalleled speed. Its streamlined, highly efficient approach reduces patient recruitment time and costs by over 50% compared to conventional trial sites, which are often overcrowded and understaffed. This exceptional performance has resulted in a 93% repeat business rate and robust growth through collaborations with top pharmaceutical companies, biotechs, and global CROs. Headquartered in Düsseldorf, ARENSIA operates with a team of 600 professionals across 8 countries.

Company Website

To learn more, please visit our website - http://www.arensia-em.com/

Next Sponsor
Back

Company Information

SGS is a leading life sciences CRO providing clinical research and bioanalytical testing with a specific focus on early stage development and biometrics. Delivering solutions in Europe and in Americas, SGS offers clinical trial (Phase I to IV) services encompassing full early phase drug development consultancy, clinical project management and monitoring, biometrics, PK/PD modeling & simulation and regulatory & medical affairs services. SGS has its own clinical unit in Belgium including a viral challenge testing facility and two phase I patients units based in Belgium and Hungary.

SGS has a wealth of expertise in FIH studies, viral challenge testing, biosimilars and complex PK/PD studies with a high therapeutic focus in Infectious Diseases, Vaccines, and Respiratory.

Company Website

To learn more, please visit our website - http://www.sgs.com/en/life-sciences/clinical-research-services

Next Sponsor
Back

Company Information

Simply sourcing comparators – we offer a unique blend of small company flexibility and speed, backed with the large-scale buying power of the Orifarm Group, which is one of the largest pharmaceutical suppliers in Europe. With over €1.4B products sold in 2021 and more than 4,000 unique product lines sourced on a monthly basis, we have unparalleled access to “out of market” and manufacturer direct buying capability, both in the US and Europe.

Company website: www.Orifarm-CTS.com

Company Website

To learn more, please visit our website - www.Orifarm-CTS.com

Next Sponsor
Back

Company Information

Syneos Health (Nasdaq:SYNH*) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together, we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to lifeTM visit SyneosHealth.com. 

Company Website

To learn more, please visit our website - www.SyneosHealth.com

Next Sponsor
Back

Company Information

Scout empowers the life sciences industry with people-first solutions: Scout Meetings, Scout Clinical, and Scout Academy. We specialize in face-to-face, virtual, and hybrid clinical meeting planning, patient payment, travel, and logistics support, and virtual collaboration and education. Since 1995, we have been a trusted partner excelling in customer service, regulatory compliance, and project delivery for leading pharmaceutical and biotechnology companies. Our deep understanding of international regulations and adaptable network of resources is built on operational experience in 109 countries. With white-glove attention to detail and a customizable, comprehensive range of services, Scout makes the complex easier. Learn more at scoutclinical.com.

Next Sponsor
Back

Company Information

Science4Tech is a dynamic scaleup dedicated to advancing clinical trials through innovative technology and rigorous data management. Our cutting-edge AI solutions empower life science companies to streamline drug development, reducing time and costs significantly. We prioritize the highest scientific standards and unwavering regulatory compliance across all phases of clinical trials.

Company Website

To learn more, please visit our website - https://s4t.health/

Next Sponsor
Back

Company Information

Worldwide is changing how the world experiences CROs – in the best possible way. From early phase, bioanalytical sciences, late phase, post-approval and real-world evidence, Worldwide Clinical Trials provides full-service drug development services for central nervous system, cardiovascular, metabolic, general medicine, oncology and rare disease therapies.

Company Website

To learn more, please visit our website - https://www.worldwide.com

Next Sponsor
Back

Company Information

Suvoda is a global clinical trial technology company specializing in complex, life-sustaining studies in therapeutic areas like oncology, central nervous system (CNS), and rare disease. Founded in 2013 by experts in eClinical technologies, Suvoda empowers clinical trial professionals to manage the most urgent moments in the most urgent trials through advanced software solutions delivered on a single platform. Headquartered outside Philadelphia, Suvoda also maintains offices in Portland, OR, Barcelona, Spain, Bucharest and Iasi, Romania, and Tokyo, Japan. The company’s Net Promoter Score (NPS) consistently exceeds the technology industry average, contributing to the company being selected by trial sponsors and CROs to support more than 1,000 trials across 80 countries.

Company Website

To learn more, please visit our website - https://www.suvoda.com/

Next Sponsor
Back

Company Information

Fortrea is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas. Our talented and diverse team of more than 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally.

Company Website

To learn more, please visit our website - https://www.fortrea.com/

Next Sponsor
Back

Company Information

Medicover Integrated Clinical Services is a unique clinical research organization with 25 years of experience.

We offer Patient Recruitment services through our own Clinical Research Network in Central and Eastern Europe with comprehensive Global Central Lab Services and access to over 8,000 tests from routine to advanced diagnostics including genetics, biomarkers, PK and PD, and PBMC isolation in more than 120 laboratories in Europe and India.

Company Website

To learn more, please visit our website - https://medicover-mics.com/

Next Sponsor
Back

Company Information

Greenphire is the industry leader of clinical payment technology, designed to improve the way research professionals work. We leverage our proprietary payments platform and workflow automation to help clients improve operational efficiency, reduce costs, mitigate regulatory risks, improve the patient and site experience and produce quantifiable results that improve clinical operations and strategic planning.

Company Website

To learn more, please visit our website - http://greenphire.com/

Next Sponsor
Back

Company Information

Myonex provides tailored services and solutions to advance medicine through clinical to commercial stages with tailored drug sourcing and ancillary supply, to packaging, labeling, and distribution. With ten global locations, we offer flexible, efficient, and cost-effective support for clients across the pharmaceutical and biotech sectors.

 

Company Website

To learn more, please visit our website - www.myonex.com

Next Sponsor
Back

Company Information

LabConnect is the world’s most agile central laboratory solutions partner supporting clinical trials of all sizes and complexity. With modern operations and strategic alliances with world-leading laboratories, LabConnect is uniquely positioned to provide access to the latest innovation and automation. LabConnect is the trusted partner for biotechnology, pharmaceutical, and clinical research organizations.

 

Follow LabConnect on LinkedIn

Learn more at labconnect.com

Company Website

To learn more, please visit our website - http://www.labconnectllc.com/

Next Sponsor
Back

Company Information

PSI is a privately-owned, full-service contract research organization (CRO), operating globally. PSI’s reputation on the market place is that of a no-nonsense CRO, capable of saving pharmaceutical sponsors millions of development dollars by consistently meeting clinical trial timelines. PSI’s global reach supports the operations of clinical trials across multiple countries.

Company Website

To learn more, please visit our website - http://www.psi-cro.com/

Next Sponsor
Back

Company Website

To learn more, please visit our website - www.evidentiq.com

Next Sponsor
Back

Company Information

Zanteris offers Clinical Operations, Project Management resourcing, and Consulting services within the Pharmaceutical industry, we use our deep expertise to identify quality solutions that help you execute your clinical study on time. Utilizing our experience of managing clinical trials across a range of medical conditions, we apply a tailored customer experience backed by strong data. Dedicated to optimized studies and risk management, our goal is to support your race in drug development.

Company Website

To learn more, please visit our website - www.zanteris.com

Next Sponsor
Back

Company Information

Endpoint Clinical is a leading clinical trial technology and service partner, delivering adaptable RTSM solutions with a focus on security, stability, and trust. With decades of expertise and a proactive, innovation-driven approach, Endpoint minimizes friction, reduces risk, and enables your teams to focus where it matters most—on trial success.

Company Website

To learn more, please visit our website - http://www.endpointclinical.com/

Next Sponsor
Back

Company Information

Signant Health provides solutions that simplify every step of the patient journey to make it easier for people to participate in, and for sites and study teams to run, clinical trials. Signant unites eCOA, eConsent, Patient Engagement, IRT, Clinical Supplies and Endpoint Quality into the industry’s most comprehensive patient-centric suite – an evolution built on more than 20 years of proven clinical research technology. Our intense focus on the patient experience, deep therapeutic area expertise and global operational scale enable hundreds of sponsors and CROs (including all Top 20 pharma) to extend the reach of drug development, expand patient opportunities and improve data quality – helping them bring life-changing therapies to our families and communities around the world.

Company Website

To learn more, please visit our website - www.signanthealth

Next Sponsor
Back

Company Website

To learn more, please visit our website - mediantechnologies.com

Why attend?

Arena International are delighted to announce 12th Annual Clinical Trials in Oncology Europe will be returning to Munich on 26-27 November 2025!

The programme will, through a variety of interactive session formats, offer insight on promoting successful collaboration between the clinical trials community and once again offer attendees practical take-aways that they can apply to their own studies.

Our Munich event will cover different perspectives of operational challenges meaning there truly is something for everyone!

Don’t miss out; join us in Munich on 26-27 November 2025!! We can’t wait to see you there!

WHAT TO EXPECT FOR 2025?

At the Clinical Trials in Oncology Europe event, taking place on 25th-26th November in Munich, we are pleased to bring together the definitive group of executives responsible for clinical operations in oncology and enhancing the partnership with vendors. There will be expert guidance through a first class conference programme and numerous networking opportunities.

150+

ATTENDEES TO MEET EACH YEAR

20+

EXHIBITORS TO MEET EACH YEAR

20+

SPEAKERS
150+

ATTENDEES TO MEET EACH YEAR

20+

EXHIBITORS TO MEET EACH YEAR
20+

SPEAKERS

WHY ATTEND?

NETWORK

This is an exceptional networking opportunity for industry accelerators. Meet industry C-Suite and Director level executives to make valuable connections at this annual thought leadership platform.

LEARN

Join like-minded peers to hear new perspectives and case studies through presentations, panel discussions and interactive round tables

ACTION

The conference discusses the vital connections between process, tools and techniques to manage change. Update your knowledge to create new strategies enabling you to enact change.

See What It's All About

Agenda

  • 26 Nov 2025
  • 27 Nov 2025
Expand All

8 AM

Registration and refreshments

8:50 AM

Chair’s opening remarks

9 AM

KEYNOTE: Effectively championing adaptive trial designs to stay nimble as the clinical research landscape continues to evolve

  • Predictions for 2026 – Are adaptive trials possible and what will they look like?
  • Enabling data-driven modifications during the trial to yield better and more useful data and solve time and resource hurdles
  • Considering the right sample size for study planning: How is this communicated to add transparency to trial design understanding and facilitate robust planning
  • Enhancing clinical trial speed, safety and effectiveness whilst remaining regulation compliant

Speakers

Christopher Bruker
Vice President Clinical Operations, Affimed

9:30 AM

Reserved for featured sponsor

10 AM

From chaos to clarity: Get to know your CRO

  • Are global CROs the only viable solution for multinational drug development clinical trials?
  • Avoiding the misalignment of incentives between service providers and biotechs to prevent sponsor dissatisfaction
  • Thinking objectively when selecting CRO partnerships by using a data-based approach rather than relying on previous relationships and trials
  • How to best implement innovative e-clinical software systems to ensure they work within the CRO universe

Speakers

Denise Lee
Vice President Clinical Operations, Heidelberg Pharma

10:30 AM

Reserved for featured sponsor

11 AM

Morning refreshments and networking

11:30 AM

PANEL DISCUSSION: Fostering a strong relationship with your CRO to make your oncology trial a success

  • How to ensure your study is prioritised in a competitive industry
  • Aligning CRO, site and sponsor priorities so everyone is supported in working towards the same goal
  • Successfully partnering a CRO team with your internal departments to allow for effective communication across all stages of the trial
  • CRO monitoring and oversight: How to make processes efficient and effective

Speakers

Denise Lee
Vice President Clinical Operations, Heidelberg Pharma
Rahul Hole
Director, Clinical Operations, Formycon
Elizabeth Emmerson
Director, Clinical Operations, Blue Earth Therapeutics

12:15 PM

Reserved for event sponsor

12:45 PM

Transforming patient enrolment campaigns to make a meaningful impact on lifesaving research

  • Integrating the right biomarker to narrow relevant patient groups and optimise and personalise disease management
  • Engaging with the oncology community and advocacy groups to grow involvement of well-informed patients
  • Leveraging investigator expertise for pragmatic trial designs and patient identification
  • Building the evidence, from natural history to endpoint development, to support informed decisions by health authorities

Speakers

Céline Adessi
Head of Clinical Sciences, Early Development Oncology, Roche

1:15 PM

Reserved for technology spotlight

1:30 PM

Lunch and networking

2:30 PM

Maximizing site engagement: A Sponsor’s perspective in the evolving clinical trial landscape

Speakers

Sarah Tissington
Director, Clinical Site Engagement, Autolus Therapeutics

3 PM

Reserved for event sponsor

3:30 PM

Afternoon refreshments and networking

4 PM

Placing fear reduction at the core of the patient experience strategy: Assessing the impact of diminished anxiety and increased sense of control for oncology clinical trials

  • Improving the sense of security to reduce unnecessary suffering and distress for patients
  • Understanding the different types of patients and their individual response behaviours
  • Being hyper aware of cultural differences and biases to ensure sensitivity and effective outcomes for all
  • Sharing best practice on effective strategies with case studies and examples to help reduce patient drop out rate

Speakers

Roel van der Heijde
Facilitator and Trainer, Roel Rotterdam & Patient Experience Association

4:30 PM

CLOSING PANEL DISCUSSION: Why do drugs fail clinical trials?

  • Changing how researchers select potential patients for better success rates
  • How to improve drug efficacy and patient safety before it’s too late
  • Back to square one: Differentiating with simpler, patient-centric protocols and optimised study design
  • Avoiding disappointing results by implementing the right technology tools to advance your trial
  • Lessons learned to mitigate trial failures

Moderator: Sumeet Ambarkhane, Chief Medical Officer, Pathios Therapeutics

Speakers

Sumeet Ambarkhane
Chief Medical Officer, Pathios Therapeutics
Céline Adessi
Head of Clinical Sciences, Early Development Oncology, Roche
Orell Mielke
Director, Global Clinical Program - Clinical Development, Immunology, CSL Behring

5:15 PM

Chair’s closing remarks

END OF DAY 1 AND NETWORKING DRINKS

8 AM

Registration and Refreshments

8:50 AM

Chair’s opening remarks

9 AM

Interactive Speaker-Hosted Roundtable Discussions

Interactive roundtable sessions offer a unique opportunity to come together with your peers to share best practice and develop solutions to critical challenges facing the industry as a whole. Each discussion will be led by a table moderator and will focus on a different challenge within oncology/ rare diseases clinical trials. Roundtables are an exciting, interactive way to build your personal network and learn from the experience and expertise of others.

After 30 minutes, delegates will have the opportunity to swap and choose a different table, and each roundtable will run twice.

Oncology Roundtables

  1. Discussing the increased role of China R&D in developing new products

Hosted by Sezcan Ozturk, Vice President, Head of Europe, Luzsana Biotechnology

  1. Innovative approaches which allow healthcare professionals to accelerate oncology research

Hosted by Elizabeth Emmerson, Director, Clinical Operations, Blue Earth Therapeutics

3. Simple solutions to complex problems: Ensuring effective communication across the clinical trial ecosystem

Speakers

Sezcan Ozturk
Vice President, Head of Europe, Luzsana Biotechnology
Elizabeth Emmerson
Director, Clinical Operations, Blue Earth Therapeutics

10 AM

Morning refreshments and networking

10:45 AM

KEYNOTE: How do you increase patient accessibility for your clinical trials to enroll the right patients while ensuring patient safety

  • Assessing the link between eligibility criteria and the potential for a serious adverse event to make an informed decision about potentially expanding the exclusion criteria of a trial
  • Discovering alternative solutions to improve patient enrollment into trials
  • Where are you getting your data for entry criteria?
  • How have the increased pressures of patient recruitment led to changing and expanding your traditional enrollment methods? What are you doing differently to increase enrollment?
  • Ensuring your entry criteria are not too conservative but remain safe so that you can reach real world populations
  • What are the criteria that are major barriers for underrepresented minorities?
  • How are you using AI to interrogate which criteria to change?

Speakers

Eslam Katab
Global Clinical Development Manager, Sandoz

11:15 AM

Reserved for event sponsor

11:45 AM

The role of patient research NGOs in drug development – illustrated by the Children’s Tumor

Foundation’s leadership role in the EU PEARL project

Speakers

Dariusz Adamczewski
Managing Director, Children’s Tumor Foundation Europe

12:15 PM

Reserved for event sponsor

12:45 PM

Lunch, networking and prize draw

2 PM

PANEL DISCUSSION: How Artificial Intelligence (AI) is powering a new era of cancer drug discovery and development

  • Moving from basic functionalities to more meaningful impact and examples of this in practice
  • When AI is progressing so quickly, how will regulation evolve to match this speed?
  • When is AI not the answer?
  • How AI has revolutionised innovative ways of collecting data, biosimulation, and early disease diagnosis for oncology trials

Speakers

Sezcan Ozturk
Vice President, Head of Europe, Luzsana Biotechnology
Stefano Ferrara
Director, Clinical Science, BeiGene
Frank Richard
Vice President Medical, Heidelberg Pharma

2:45 PM

Reserved for event sponsor

3:15 PM

Designing appropriate and patient-focused oncology trials to reduce patient and site burden

  • Understanding site processes and expectations to reduce delays in site initiation, activation, and screening for potential patients
  • Championing collaborative sites for a streamlined trial
  • Can we ever be appropriately equipped for adverse effects with off-site testing?

Speakers

Stefano Ferrara
Director, Clinical Science, BeiGene

3:45 PM

Session reserved for GlobalData

4:15 PM

Chair’s closing remarks

END OF CONFERENCE

Speakers

Select a speaker to learn more

Back
Christopher Bruker
Vice President Clinical Operations, Affimed

Strategic and globally experienced clinical operations leader with deep expertise in oncology drug development - spanning immuno-oncology, cell therapies, and both solid tumour and haematologic malignancies. I lead complex programs across Europe, North America, and AsiaPac, consistently translating clinical complexity into decisive, value-driven execution within biotech, pharmaceutical, and CRO environments.
I offer a global perspective, having led international teams, managed cross-border trials, and engaged directly with regulators including the FDA, EMA, MHRA, BfArM, MFDS, and others. Fully authorized to work in both the EU and the United States, I navigate regulatory diversity, cultural dynamics, and operational complexity with agility and precision.
As a people-first leader with high emotional intelligence, I build, coach, and retain high-performing global teams - driving accountability, strategic alignment, and performance while balancing innovation with compliance.
I deliver value by:

• Driving complex clinical trials from first-in-human through pivotal phases - including NK cell therapies - by eliminating operational barriers through data-driven decisions, strategic foresight, and implementation of scalable, inspection-ready systems.
• Leading global stakeholder alignment and regulatory execution, securing executive buy-in, managing multi-million-dollar budgets and vendor oversight, and contributing to successful submissions, inspections, and expedited pathways such as FDA Fast Track and RMAT designations.
• Elevating operational quality and compliance by strengthening systems, ensuring audit readiness, and embedding a culture of continuous improvement across functional teams.
Throughout every engagement, I bring clarity to complexity - transforming strategic vision into operational results that accelerate access to transformative therapies.

Session Details:

KEYNOTE: Effectively championing adaptive trial designs to stay nimble as the clinical research landscape continues to evolve

2025-11-26, 9:00 AM

View In Agenda
Next speaker
Back
Sarah Tissington
Director, Clinical Site Engagement, Autolus Therapeutics

Sarah is a clinical research professional with over 25 years of international experience spanning the medical device, pharmaceutical, biotech, and CRO sectors. Her background includes a strong focus on leadership in clinical operations, site engagement, and patient recruitment strategies across diverse therapeutic areas including oncology, infectious diseases, immunology, and vaccines.

Sarah has recently joined Autolus as Director of Clinical Site Engagement, where she will be supporting the planning and execution of site engagement strategies to drive clinical trial success. Prior to this, she served as Regional Director for Clinical Site Management & Monitoring (EU/UK) at Moderna, and held global and regional leadership roles at Biogen, AbbVie, Novartis, Janssen-Cilag and IQVIA, driving patient-centric trial strategies and enhancing site performance.

Sarah lives in the Cotswolds with her three daughters and two dogs, and in her spare time, practices yoga as much as possible.

Session Details:

Maximizing site engagement: A Sponsor’s perspective in the evolving clinical trial landscape

2025-11-26, 2:30 PM

View In Agenda
Next speaker
Back
Dariusz Adamczewski
Managing Director, Children’s Tumor Foundation Europe

I’m a Medical Doctor (MD) and public administration expert with over 20 years of experience dedicated to improving patient outcomes globally through clinical practice, health policy, advocacy, and healthcare management. My expertise spans cardiology, oncology, immunology, public health, and particularly rare diseases such as neurofibromatosis (NF). As Managing Director of the Children’s Tumor Foundation Europe, I lead initiatives focused on improving care, policy, and research collaboration for NF, driving meaningful partnerships across patient communities, clinical networks, EU institutions, and industry.

I’ve previously held senior roles in both government (Ministry of Health, Poland) and industry (Johnson & Johnson, Pfizer), where I successfully influenced health system reforms, including oncology, cardiology, family medicine, emergency medicine, health policy frameworks, coordinated clinical trials, and led high-level stakeholder engagement across the EMEA region. My experience includes developing national health programs, EU regulatory advocacy, clinical trials management, and patient-centered care strategies that have significantly enhanced access and care quality.

I am deeply committed to using policy, innovation, and collaboration to create tangible improvements for patients and healthcare systems. Let’s connect to discuss partnerships, advisory roles, or collaborative projects aimed at transforming healthcare for patients across Europe and beyond.

Session Details:

The role of patient research NGOs in drug development – illustrated by the Children’s Tumor

2025-11-27, 11:45 AM

View In Agenda
Next speaker
Back
Orell Mielke
Director, Global Clinical Program - Clinical Development, Immunology, CSL Behring

For over 20 years, I have worked as a leader in pharmaceutical companies. As a rather quiet, "introverted" type, I initially felt like an outsider in my leadership role. Today, I see many loud leaders who talk a lot and tell others what to do. The result is usually disappointing. 𝐈𝐧𝐭𝐞𝐥𝐥𝐢𝐠𝐞𝐧𝐭 𝐩𝐞𝐨𝐩𝐥𝐞 𝐝𝐨 𝐧𝐨𝐭 𝐰𝐚𝐧𝐭 𝐭𝐨 𝐛𝐞 𝐝𝐢𝐫𝐞𝐜𝐭𝐞𝐝; 𝐭𝐡𝐞𝐲 𝐰𝐚𝐧𝐭 𝐭𝐨 𝐡𝐚𝐯𝐞 𝐭𝐡𝐞𝐢𝐫 𝐨𝐰𝐧 𝐚𝐡𝐚 𝐦𝐨𝐦𝐞𝐧𝐭𝐬.

Session Details:

CLOSING PANEL DISCUSSION: Why do drugs fail clinical trials?

2025-11-26, 4:30 PM

View In Agenda
Next speaker
Back
Clara Cali Mella
Senior Analytics and Insights Manager, Bayer
Next speaker
Back
Stefano Ferrara
Director, Clinical Science, BeiGene

Stefano Ferrara is a Clinical Development Expert and Director of Clinical Science at BeiGene, specializing in oncology clinical development with a focus on innovative cancer treatments. With over 20 years of leadership in global oncology clinical trials, he has played key roles at Celgene Corp, Novartis Pharma, and Sanofi-Aventis, specializing in GI, Lung, GU, and Pediatric cancers. Stefano is passionate about increasing accessibility to cancer treatment globally. He holds a strong commitment to humanitarian efforts as a supporter of Save the Children. Stefano brings his expertise in both science and advocacy to his role on the advisory board

Session Details:

PANEL DISCUSSION: How Artificial Intelligence (AI) is powering a new era of cancer drug discovery and development

2025-11-27, 2:00 PM

Session Details:

Designing appropriate and patient-focused oncology trials to reduce patient and site burden

2025-11-27, 3:15 PM

View In Agenda
Next speaker
Back
Nikolina Krajnovic
Director Clinical Operational Execution, BioNTech

Lean management / line management
Main line management tasks: people development through trainings, coachings and sit-ins, performance assesments, resourcing
Main process improvment tasks: structured problem solving sessions, interface coordination, SOP reviews, assesments and updates, quality systems development
Main project delivery tasks: responsibility for project delivery within given timelines, budget and quality

Next speaker
Back
Elizabeth Emmerson
Director, Clinical Operations, Blue Earth Therapeutics

Session Details:

PANEL DISCUSSION: Fostering a strong relationship with your CRO to make your oncology trial a success

2025-11-26, 11:30 AM

Session Details:

Interactive Speaker-Hosted Roundtable Discussions

2025-11-27, 9:00 AM

View In Agenda
Next speaker
Back
Rahul Hole
Director, Clinical Operations, Formycon

A seasoned Clinical Research leader with 19 years of relevant experience in handling global clinical trials in multiple therapeutic areas- Oncology, Endocrinology, Immunology, Cardiology, Ophthalmology, Gastroenterology, Vaccines and Respiratory. Extensive experience in biosimilar development for more than 12 years

Session Details:

PANEL DISCUSSION: Fostering a strong relationship with your CRO to make your oncology trial a success

2025-11-26, 11:30 AM

View In Agenda
Next speaker
Back
Erela Dans
Director for Neurology and Immunology, GlobalData
Next speaker
Back
Denise Lee
Vice President Clinical Operations, Heidelberg Pharma

Dynamic and passionate biopharma leader with over 25 years of global expertise spanning clinical practice and R&D, and CROs. A problem-solver and strategist at heart, I thrive on tackling challenges. As a Managing Director and servant leader, I have driven operational excellence and transformed business critical processes. Through empathy and empowerment, I have led diverse international teams with less than 10% employee turnover.

In my current role, I saved over $2 million USD within six months through renegotiation and introduction of efficiencies, while doubling our satisfaction with vendors via introduction of governance structures and key performance, quality, and risk indicators.

Deeply committed to ethical and sustainable practices, I leverage data-driven decision-making to align vision, mission, and objectives with impactful outcomes. I bring energy, focus, and leadership to every initiative, ensuring excellence and meaningful contributions to healthcare.

Session Details:

PANEL DISCUSSION: Fostering a strong relationship with your CRO to make your oncology trial a success

2025-11-26, 11:30 AM

Session Details:

From chaos to clarity: Get to know your CRO

2025-11-26, 10:00 AM

View In Agenda
Next speaker
Back
Frank Richard
Vice President Medical, Heidelberg Pharma

Frank has been working in the past in Immune-Oncology, Immunology& Respiratory, Rare Hematology Diseases and Iron Metabolism across big pharma and biotech.

Frank holds a MD from Charité Medical University, Berlin, an MBA from University of Applied Sciences, Neu-Ulm, and is a board-certified Clinical Pharmacologist.

Additionally, he exerts an unique expertise and interest in Bayesian Statistics and machine learning in Pharma and Biotech.

Session Details:

PANEL DISCUSSION: How Artificial Intelligence (AI) is powering a new era of cancer drug discovery and development

2025-11-27, 2:00 PM

View In Agenda
Next speaker
Back
Sezcan Ozturk
Vice President, Head of Europe, Luzsana Biotechnology

Session Details:

Interactive Speaker-Hosted Roundtable Discussions

2025-11-27, 9:00 AM

Session Details:

PANEL DISCUSSION: How Artificial Intelligence (AI) is powering a new era of cancer drug discovery and development

2025-11-27, 2:00 PM

View In Agenda
Next speaker
Back
Sumeet Ambarkhane
Chief Medical Officer, Pathios Therapeutics

Physician-scientist (MD) with over 20 years experience covering clinical care, early / translational & late drug development & executive leadership in global Oncology-Hematology & Immunology, regulatory submissions-approvals and commercialization. Special interest in development of targeted and novel therapies for severe diseases with unmet need. Maintains excellent network with the global medical & thought leader community as well as various specialists and consultants. Visionary, value-driven, passionate, sympathetic and efficient leader to bring along organizational transformation.

Session Details:

CLOSING PANEL DISCUSSION: Why do drugs fail clinical trials?

2025-11-26, 4:30 PM

View In Agenda
Next speaker
Back
Dr. Cornelia Dechant
Co-Founder of International Porphyria Patient Network, Patient Advocate
Next speaker
Back
Jenifer Waldrop
Executive Director, Rare Disease Diversity Coalition
Next speaker
Back
Céline Adessi
Head of Clinical Sciences, Early Development Oncology, Roche

More than 20 years of experience in pharmaceutical companies, with strong research, pre-clinical, clinical safety and regulatory expertize in different therapeutic areas (neuroscience, metabolism and oncology). For 10 years, acted as project/ team leader and laboratory head, leading various pre-clinical therapeutic and diagnostic programs. Since 2007 held positions of increasing responsibility in the Product Development-Clinical Safety Community at Hoffmann-la Roche. Currently, Senior Group Director, managing a team of safety science professionals working on early clinical development oncology programs and in/out licensing opportunities. Gained recently additional FDA and EU regulatory filing experience, acting as regulatory project manager for the first Roche bispecific T-cell engaging therapy for a hematology malignancy indication.

Highly motivated to expand my professional career in a further global strategic and managerial role. Seeking opportunities at the edge of science, drug development, with a focus on strategic alliances with internal and external partners.

Session Details:

Transforming patient enrolment campaigns to make a meaningful impact on lifesaving research

2025-11-26, 12:45 PM

Session Details:

CLOSING PANEL DISCUSSION: Why do drugs fail clinical trials?

2025-11-26, 4:30 PM

View In Agenda
Next speaker
Back
Roel van der Heijde
Facilitator and Trainer, Roel Rotterdam & Patient Experience Association

Roel van der Heijde lives in Rotterdam, The Netherlands. He has a MA in International Business, is an international acknowledged NLP trainer, executive team coach and a certified death and grief counsellor.

He is a driven and experienced trainer and facilitator in:

  • - Patient Fear Reduction (for all caregivers);
  • - Team Collaboration;
  • - Vulnerability & Leadership;
  • - Discrimination & Inclusion.

Roels motivation: “Acknowledgement and recognition of the fears and emotions of our patients are the basis for excellent patient experience and patient safety”.

“Working with Groups I experience as thoroughly fascinating and inspiring. In interaction with groups I am every time amazed by the enormous potential of practical knowledge and direct experience that lies hidden in groups and that is so easily overlooked. Herein lies the basis for excellent vulnerable leadership.

Session Details:

Placing fear reduction at the core of the patient experience strategy: Assessing the impact of diminished anxiety and increased sense of control for oncology clinical trials

2025-11-26, 4:00 PM

View In Agenda
Next speaker
Back
Eslam Katab
Global Clinical Development Manager, Sandoz

Session Details:

KEYNOTE: How do you increase patient accessibility for your clinical trials to enroll the right patients while ensuring patient safety

2025-11-27, 10:45 AM

View In Agenda
Next speaker
Back
Stéphane Wilzius
Head of Clinical Operations a.i., Santhera Pharmaceuticals
Next speaker
Back
Channa Debruyne
Global Clinical Development Lead, Late stage & LCM Oncology, Servier

Advisory Board

Select a member to learn more

Back
Cesare Spadoni

Cesare is co-founder and Chief Operating Officer of Oncoheroes Biosciences Inc., a Boston-based biotech company focused on pediatric oncology drug development. Cesare has more than 20 years of experience in the drug development field, in both scientific and commercial roles. Previously, he held senior positions at AMRI, Aptuit Laurus, ThalesNano and Auxiliis. Cesare started his career as research scientist in a pharmaceutical company (Eisai, London) and in academia (Institute of Enzymology, Budapest).

Following the death of his first daughter Laura to cancer, Cesare set up aPODD Foundation, a London-based charity focused on accelerating paediatric oncology drug development. As aPODD’s chairman he is actively involved on a pro-bono basis in drug repurposing projects, advocacy efforts and research collaborations.

Cesare holds an MSc in Applied Molecular Biology and a PhD in Neurosciences from UCL, University of London, as well as an MBA from the Central European University, Budapest.

Next
Back
Stefano Ferrara

Stefano Ferrara is a Clinical Development Expert and Director of Clinical Science at BeiGene, specializing in oncology clinical development with a focus on innovative cancer treatments. With over 20 years of leadership in global oncology clinical trials, he has played key roles at Celgene Corp, Novartis Pharma, and Sanofi-Aventis, specializing in GI, Lung, GU, and Pediatric cancers. Stefano is passionate about increasing accessibility to cancer treatment globally. He holds a strong commitment to humanitarian efforts as a supporter of Save the Children. Stefano brings his expertise in both science and advocacy to his role on the advisory board

Next
Back
Fatima Scipione

Fatima serves as the Vice President of Global Patient Affairs at Blueprint Medicines, a global, fully integrated biopharmaceutical company that invents life-changing medicines. We seek to alleviate human suffering by solving important medical problems in two core focus areas: allergy/inflammation and oncology/hematology.

In her role, Fatima leads transformative collaborations with external advocacy groups, empowering and educating those affected by systemic mastocytosis. She has led the launch of significant initiatives such as GRTY Health’s SM patient platform, MastoConnect (https://mastoconnect.com), and Colors of SM (https://www.colorsofsm.com/), in partnership with the advocacy community, and actively chairs the Equity, Diversity, and Inclusion (ED&I) patient committee, which looks to address the needs of marginalized and underrepresented communities.

With over two decades of experience in the biopharma sector, Fatima is a dedicated and passionate advocate for patients. Celebrated by PharmaVoice 100 as one of the most inspiring leaders in patient advocacy, her work focuses on amplifying patient voices and harnessing the collective power of individuals to make a positive impact. Fatima is committed to enhancing patient engagement in the development of transformative medicines, ensuring that the patient perspective is integral to every stage of the process.

She inspires her colleagues to foster a culture of purpose-driven advocacy, ensuring that patient welfare remains at the forefront of their mission. Beyond her professional role, Fatima is deeply involved in civic activities, continually dedicating herself to enhancing patient welfare and advocacy on a broader scale.

Plan Your Visit

Venue

Marriott Munich City West , Munich, Germany

Book Your Stay

Accommodation

Arena International Events Group “(Arena”) is aware of numerous third-party agencies which are contacting Arena’s customers and purporting to have access to hotel room bookings, events attendee lists and selling unsolicited services. It is unclear whether the agencies in question are in possession of such information, or whether they intend to scam unsuspecting customers. Whilst Arena International Events Group pursues such third-party companies for their potentially illicit activity, Arena encourages you to be cautious in engaging with such third-party agencies and Arena shall not accept any responsibility for any losses incurred by you should you choose to engage with third parties that have no affiliation to Arena International Events Group..

2025 Sponsors

Select a sponsor to learn more

FEATURED SPONSOR

SESSION SPONSOR

EXHIBITOR

CO-Sponsors

Why partner?

 

Contact us to become a partner

Partnership Opportunities

We work with you to design a bespoke package to meet your business needs, where you could:

  • Demonstrate your expertise on the agenda – have the attention of the entire audience. For greatest impact, why not position your talk before a networking break and immediately conduct follow up conversations with highly engaged attendees
  • Showcase your business and its services at an exhibition booth, which provides a perfect meeting place for prospective new clients
    Present the value proposition of your offering over your competitors, in front of an audience of active, engaged potential customers
  • Speak with key decision makers as part of our intimate, interactive roundtable style workshop sessions with over 8 hours allowed for networking

Event reach

  • 150+ attendees each year
  • 80% attendees C-suite level

 

Take a look at our current sponsors

Media Centre

MEDIA PARTNERS

Become A Media Partner

Enquiry

Contact Us

SPONSORSHIP ENQUIRIES

Conor Taylor

+44 (0)20 7936 6870

SPEAKING OPPORTUNITIES

Maya Hudson

Deputy Head of Production

+44 204540 7766

MARKETING ENQUIRIES

Moona Popal

Marketing Manager

DELEGATE ENQUIRIES

Sunny Saikia

VIP Delegate Manager

SPONSORSHIP ENQUIRIES

To enquire about sponsorship opportunities for the conference, please contact:

Conor Taylor

 


+44 (0)20 7936 6870

SPEAKER ENQUIRES

The program for the event is underway. Please get in touch with the program director if you would like to be part of the program:

Niki Khoshkbary

Portfolio Manager


+44 (0)20 4540 7545